Terms: = Prostate cancer AND WFDC2, EDDM4, HE4, WAP5, dJ461P17.6
15 results:
1. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
[TBL] [Abstract] [Full Text] [Related]
2. A digital image colorimetry system based on smart devices for immediate and simultaneous determination of enzyme-linked immunosorbent assays.
Mirhosseini S; Nasiri AF; Khatami F; Mirzaei A; Aghamir SMK; Kolahdouz M
Sci Rep; 2024 Jan; 14(1):2587. PubMed ID: 38297148
[TBL] [Abstract] [Full Text] [Related]
3. Development and evaluation of the MiCheck® prostate test for clinically significant prostate cancer.
Shore ND; Polikarpov DM; Pieczonka CM; Henderson RJ; Bailen JL; Saltzstein DR; Concepcion RS; Beebe-Dimmer JL; Ruterbusch JJ; Levin RA; Wissmueller S; Le TH; Gillatt DA; Chan DW; Deng N; Siddireddy JS; Lu Y; Campbell DH; Walsh BJ
Urol Oncol; 2023 Nov; 41(11):454.e9-454.e16. PubMed ID: 37734979
[TBL] [Abstract] [Full Text] [Related]
4. Flexible diagnostic measures and new cut-point selection methods under multiple ordered classes.
Feng Y; Tian L
Pharm Stat; 2022 Jan; 21(1):220-240. PubMed ID: 34449107
[TBL] [Abstract] [Full Text] [Related]
5. Nanotechnology in ovarian cancer: Diagnosis and treatment.
Barani M; Bilal M; Sabir F; Rahdar A; Kyzas GZ
Life Sci; 2021 Feb; 266():118914. PubMed ID: 33340527
[TBL] [Abstract] [Full Text] [Related]
6. wfdc2 suppresses prostate cancer metastasis by modulating EGFR signaling inactivation.
Xiong Y; Yuan L; Chen S; Xu H; Peng T; Ju L; Wang G; Xiao Y; Wang X
Cell Death Dis; 2020 Jul; 11(7):537. PubMed ID: 32678075
[TBL] [Abstract] [Full Text] [Related]
7. Pediatric population reference value distributions for cancer biomarkers and covariate-stratified reference intervals in the CALIPER cohort.
Bevilacqua V; Chan MK; Chen Y; Armbruster D; Schodin B; Adeli K
Clin Chem; 2014 Dec; 60(12):1532-42. PubMed ID: 25261558
[TBL] [Abstract] [Full Text] [Related]
8. prostate specific antigen enhances the innate defence of prostatic epithelium against Escherichia coli infection.
Townes CL; Ali A; Gross N; Pal D; Williamson S; Heer R; Robson CN; Pickard RS; Hall J
Prostate; 2013 Oct; 73(14):1529-37. PubMed ID: 23818154
[TBL] [Abstract] [Full Text] [Related]
9. Potential role of he4 in multimodal screening for epithelial ovarian cancer.
Urban N; Thorpe JD; Bergan LA; Forrest RM; Kampani AV; Scholler N; O'Briant KC; Anderson GL; Cramer DW; Berg CD; McIntosh MW; Hartge P; Drescher CW
J Natl Cancer Inst; 2011 Nov; 103(21):1630-4. PubMed ID: 21917606
[TBL] [Abstract] [Full Text] [Related]
10. Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer.
Kim JH; Dhanasekaran SM; Prensner JR; Cao X; Robinson D; Kalyana-Sundaram S; Huang C; Shankar S; Jing X; Iyer M; Hu M; Sam L; Grasso C; Maher CA; Palanisamy N; Mehra R; Kominsky HD; Siddiqui J; Yu J; Qin ZS; Chinnaiyan AM
Genome Res; 2011 Jul; 21(7):1028-41. PubMed ID: 21724842
[TBL] [Abstract] [Full Text] [Related]
11. Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.
Cramer DW; Bast RC; Berg CD; Diamandis EP; Godwin AK; Hartge P; Lokshin AE; Lu KH; McIntosh MW; Mor G; Patriotis C; Pinsky PF; Thornquist MD; Scholler N; Skates SJ; Sluss PM; Srivastava S; Ward DC; Zhang Z; Zhu CS; Urban N
Cancer Prev Res (Phila); 2011 Mar; 4(3):365-74. PubMed ID: 21372036
[TBL] [Abstract] [Full Text] [Related]
12. Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.
Köbel M; Kalloger SE; Boyd N; McKinney S; Mehl E; Palmer C; Leung S; Bowen NJ; Ionescu DN; Rajput A; Prentice LM; Miller D; Santos J; Swenerton K; Gilks CB; Huntsman D
PLoS Med; 2008 Dec; 5(12):e232. PubMed ID: 19053170
[TBL] [Abstract] [Full Text] [Related]
13. Marked gene transcript level alterations occur early during radical prostatectomy.
Schlomm T; Näkel E; Lübke A; Buness A; Chun FK; Steuber T; Graefen M; Simon R; Sauter G; Poustka A; Huland H; Erbersdobler A; Sültmann H; Hellwinkel OJ
Eur Urol; 2008 Feb; 53(2):333-44. PubMed ID: 17448597
[TBL] [Abstract] [Full Text] [Related]
14. Proteins with whey-acidic-protein motifs and cancer.
Bouchard D; Morisset D; Bourbonnais Y; Tremblay GM
Lancet Oncol; 2006 Feb; 7(2):167-74. PubMed ID: 16455481
[TBL] [Abstract] [Full Text] [Related]
15. Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling.
Gilks CB; Vanderhyden BC; Zhu S; van de Rijn M; Longacre TA
Gynecol Oncol; 2005 Mar; 96(3):684-94. PubMed ID: 15721412
[TBL] [Abstract] [Full Text] [Related]
